prospectively validate a fibronectin-aggrecan complex as a biomarker for response to ESI for radiculopathy with HNP
We will measure levels of the protein complex in the epidural space of patients undergoing lumbar ESI for radiculopathy with HNP. We assess functional outcomes at baseline and after treatment with the Medical Outcomes Study Short Form-36 instrument (SF-36). Our hypothesis was that the complex is present in patients with clinically significant functional improvement after ESI.
Study Type
OBSERVATIONAL
Enrollment
26
functional outcome on SF-36 following ESI
Time frame: 2-6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.